{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:46:40Z","timestamp":1791298000537,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/pas.0b013e318190d12e","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T06:01:25Z","timestamp":1242885685000},"page":"599-608","source":"Crossref","is-referenced-by-count":170,"title":["Observer Variation in the Application of the Pheochromocytoma of the Adrenal Gland Scaled Score"],"prefix":"10.1097","volume":"33","author":[{"given":"David","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Tischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo V.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"DeLellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francien","family":"van Nederveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210131","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/modpathol.3800160","article-title":"CGH and CD 44\/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas","volume":"17","author":"August","year":"2004","journal-title":"Mod Pathol"},{"key":"R2-15-20210131","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1583::AID-CNCR28>3.0.CO;2-#","article-title":"Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: a positive correlation between MIB-1 staining and malignant tumor behavior","volume":"86","author":"Brown","year":"1999","journal-title":"Cancer"},{"key":"R3-15-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.1997.2240838.x","article-title":"Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas","volume":"31","author":"Castilla-Guerra","year":"1997","journal-title":"Histopathology"},{"key":"R4-15-20210131","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0046-8177(98)90070-3","article-title":"Prognostic markers in pheochromocytoma","volume":"29","author":"Clarke","year":"1998","journal-title":"Hum Pathol"},{"key":"R5-15-20210131","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1445-2197.1991.tb00323.x","article-title":"Prognostic significance of nuclear DNA content in phaeochromocytoma","volume":"61","author":"Cope","year":"1991","journal-title":"Aust N Z J Surg"},{"key":"R6-15-20210131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9896(199905)188:1<51::AID-PATH310>3.0.CO;2-R","article-title":"Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas","volume":"188","author":"de Krijger","year":"1999","journal-title":"J Pathol"},{"key":"R7-15-20210131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/EP:17:2:137","article-title":"New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas","volume":"17","author":"de Krijger","year":"2006","journal-title":"Endocr Pathol"},{"key":"R8-15-20210131","first-page":"147","article-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumour of Endocrine Organs","author":"DeLellis","year":"2004"},{"key":"R9-15-20210131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jso.20177","article-title":"Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor","volume":"89","author":"Elder","year":"2005","journal-title":"J Surg Oncol"},{"key":"R10-15-20210131","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MP.0000056982.07160.E3","article-title":"KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma","volume":"16","author":"Elder","year":"2003","journal-title":"Mod Pathol"},{"key":"R11-15-20210131","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.urology.2006.02.019","article-title":"Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas","volume":"68","author":"Gao","year":"2006","journal-title":"Urology"},{"key":"R12-15-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10689-004-5740-1","article-title":"Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx","volume":"4","author":"Gimm","year":"2005","journal-title":"Fam Cancer"},{"key":"R13-15-20210131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00022744-200012000-00003","article-title":"Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2\/neu in adrenal and extra-adrenal pheochromocytomas","volume":"8","author":"Gupta","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R14-15-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","article-title":"Pheochromocytomas: can malignant potential be predicted?","volume":"53","author":"John","year":"1999","journal-title":"Urology"},{"key":"R15-15-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1385\/EP:13:2:099","article-title":"N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma","volume":"13","author":"Khorram-Manesh","year":"2002","journal-title":"Endocr Pathol"},{"key":"R16-15-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/EP:16:1:023","article-title":"Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors","volume":"16","author":"Kimura","year":"2005","journal-title":"Endocr Pathol"},{"key":"R17-15-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/EP:13:2:149","article-title":"Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques","volume":"13","author":"Kumaki","year":"2002","journal-title":"Endocr Pathol"},{"key":"R18-15-20210131","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0046-8177(90)90155-X","article-title":"Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features","volume":"21","author":"Linnoila","year":"1990","journal-title":"Hum Pathol"},{"key":"R19-15-20210131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/jsre.2002.6451","article-title":"Differential heparanase-1 expression in malignant and benign pheochromocytomas","volume":"108","author":"Quiros","year":"2002","journal-title":"J Surg Res"},{"key":"R20-15-20210131","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00000478-200111000-00010","article-title":"Increased expression of tenascin in pheochromocytomas correlates with malignancy","volume":"25","author":"Salmenkivi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R21-15-20210131","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/ASO.2003.04.007","article-title":"Flow cytometric DNA analysis for determination of malignant potential in adrenal pheochromocytoma or paraganglioma: an Indian experience","volume":"10","author":"Shah","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R22-15-20210131","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R23-15-20210131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<175::AID-PATH615>3.0.CO;2-Z","article-title":"Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?","volume":"191","author":"van der Harst","year":"2000","journal-title":"J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000478-200904000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:39Z","timestamp":1786038819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-200904000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e318190d12e","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}